Detalles de la búsqueda
1.
Evaluation of the prognostic significance of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) validation study.
J Transl Med
; 13: 171, 2015 May 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-26021752
2.
Randomized phase III clinical trial comparing the combination of capecitabine and oxaliplatin (CAPOX) with the combination of 5-fluorouracil, leucovorin and oxaliplatin (modified FOLFOX6) as adjuvant therapy in patients with operated high-risk stage II or stage III colorectal cancer.
BMC Cancer
; 15: 384, 2015 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-25956750
3.
Docetaxel and carboplatin combination chemotherapy as outpatient palliative therapy in carcinoma of unknown primary: a multicentre Hellenic Cooperative Oncology Group phase II study.
Acta Oncol
; 47(6): 1148-55, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-18607872
4.
Evaluation of the prognostic value of all four HER family receptors in patients with metastatic breast cancer treated with trastuzumab: A Hellenic Cooperative Oncology Group (HeCOG) study.
PLoS One
; 13(12): e0207707, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30521571
5.
Evaluation of the Insulin-like Growth Factor Receptor Pathway in Patients with Advanced Breast Cancer Treated with Trastuzumab.
Cancer Genomics Proteomics
; 15(6): 461-471, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30343280
6.
A phase I-II study of bi-weekly gemcitabine and irinotecan as second-line chemotherapy in non-small cell lung cancer after prior taxane + platinum-based regimens.
Cancer Chemother Pharmacol
; 59(1): 51-9, 2007 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-16622691
7.
The Prognostic Value of the Immunohistochemical Expression of Phosphorylated RB and p16 Proteins in Association with Cyclin D1 and the p53 Pathway in a Large Cohort of Patients with Breast Cancer Treated with Taxane-based Adjuvant Chemotherapy.
Anticancer Res
; 37(6): 2947-2957, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28551632
8.
Combination of topotecan and cisplatin in relapsed patients with small cell lung cancer: a phase II study of the hellenic cooperative oncology group (HeCOG).
Cancer Chemother Pharmacol
; 57(2): 207-12, 2006 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-16028103
9.
Expression of p27KIP1, p21WAF1 and p53 does not correlate with prognosis in node-negative invasive ductal carcinoma of the breast.
Anticancer Res
; 26(2B): 1657-68, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-16619588
10.
Lessons from the past: Long-term safety and survival outcomes of a prematurely terminated randomized controlled trial on prophylactic vs. hemoglobin-based administration of erythropoiesis-stimulating agents in patients with chemotherapy-induced anemia.
Mol Clin Oncol
; 4(2): 211-220, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26893865
11.
An overview of current results with the gemcitabine and docetaxel combination as initial and salvage chemotherapy regimen in advanced non-small cell lung cancer.
Crit Rev Oncol Hematol
; 45(3): 265-75, 2003 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-12633839
12.
The effect of temozolomide-based chemotherapy in patients with cerebral metastases from melanoma.
Melanoma Res
; 14(4): 289-94, 2004 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-15305160
13.
Tolerability of adjuvant high-dose interferon alfa-2b: 1 month versus 1 year--a Hellenic Cooperative Oncology Group study.
Anticancer Res
; 24(3b): 1947-52, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-15274382
14.
Lymphocyte subpopulations and interleukin levels in high-risk melanoma patients treated with high-dose interferon A-2B.
Am J Clin Oncol
; 25(6): 591-6, 2002 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-12478006
15.
Serglycin is implicated in the promotion of aggressive phenotype of breast cancer cells.
PLoS One
; 8(10): e78157, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-24205138
16.
Report of the long-term efficacy of two cycles of adjuvant bleomycin/etoposide/cisplatin in patients with stage I testicular nonseminomatous germ-cell tumors (NSGCT): a risk adapted protocol of the Hellenic Cooperative Oncology Group.
Urol Oncol
; 29(2): 189-93, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-19362863
17.
Monoclonal antibodies in the management of solid tumors.
Curr Top Med Chem
; 6(16): 1687-705, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-17017951
18.
The combination of gemcitabine and carboplatin as first-line treatment in patients with advanced urothelial carcinoma. A Phase II study of the Hellenic Cooperative Oncology Group.
Cancer
; 106(2): 297-303, 2006 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-16342065
19.
A phase II study of the docetaxel-ifosfamide-carboplatin combination in advanced non-small-cell lung cancer.
Oncology
; 69(4): 333-41, 2005.
Artículo
en Inglés
| MEDLINE | ID: mdl-16282711
20.
Paclitaxel and carboplatin as first-line chemotherapy combined with gefitinib (IRESSA) in patients with advanced breast cancer: a phase I/II study conducted by the Hellenic Cooperative Oncology Group.
Breast Cancer Res Treat
; 92(1): 1-9, 2005 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-15980985